A CROSS SECTIONAL STUDY OF PREVALENCE OF METABOLIC SYNDROME (AS PER DEFINITION OF NCEP-ATP3) IN PATIENTS ATTENDING TERTIARY CARE HOSPITAL IN COAL - CAPITAL OF INDIA, DHANBAD

Main Article Content

Dr. Neelam Agrawal
Dr. Ruchi Shree
Dr. Mahto Hemanti Raghu
Dr. S.K. Verma

Keywords

Metabolic Syndrome, NCEP-ATP III, Prevalence, Obesity, Hypertension, Dyslipidemia, Insulin Resistance.

Abstract

Background: This study was conducted to ascertain the prevalence of metabolic syndrome in patients undergoing treatment at a tertiary care facility in Dhanbad, India's coal capital, as determined by the NCEP-ATP III criteria.


Methods: Over the course of July to November, a cross-sectional observational study was carried out in Shaheed Nirmal Mahato Medical College, Dhanbad. Consecutive sampling was used to enroll 300  patients (≥18 years old) who were enrolled in both inpatient and outpatient departments. A pre-tested structured questionnaire, physical examination, and laboratory studies were used to gather data on sociodemographic, clinical, and biochemical parameters. The NCEP-ATP III criteria were used to diagnose metabolic syndrome. SPSS was used for the statistical analysis, and a p-value of less than 0.05 was deemed statistically significant.


Result: 32.7% of people had metabolic syndrome overall. Of the participants in the study, 46.7% were women and 53.3% were men. Females had a significantly higher prevalence (38.6%) than males (27.5%) (p=0.04). As people aged, the prevalence rose, reaching 52.2% in those over 60 (p<0.001). The most frequent abnormalities among the individual components were low HDL cholesterol (45.3%) and elevated blood pressure (49.3%), followed by abdominal obesity (40.7%), fasting hyperglycemia (38.7%), and hypertriglyceridemia (36.7%). There was no discernible link between metabolic syndrome and alcohol or tobacco use.


Conclusion: Metabolic syndrome is highly prevalent in this population, especially among females and older individuals. Early screening and lifestyle interventions are essential to reduce future cardiovascular and metabolic risks.

Abstract 73 | pdf Downloads 42

References

[1] Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640-5.
[2] Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. The Journal of Clinical Endocrinology & Metabolism 2008;93(11 Suppl 1):s9-30.
[3] National Cholesterol Education Program (NCEP) Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19), 2486-97.
[4] Deepa M, Farooq S, Deepa R, et al. Prevalence of metabolic syndrome using WHO, ATP III and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes/Metabolism Research and Reviews 2007;23(2):127-34.
[5] Gupta R, Misra A, Vikram NK, et al. Younger age of onset of diabetes mellitus and cardiovascular risk factors in Asian Indian subjects. BMC Cardiovascular Disorders 2004;4(1):1-8.
[6] Sawant A, Mankeshwar R, Shah S, et al. Prevalence of metabolic syndrome in urban India. Chronic Diseases and Translational Medicine 2011;57(3):142-9.
[7] Pandit K, Goswami S, Ghosh S, et al. Metabolic syndrome in South Asians. Indian J Endocrinol Metab 2012;16(1):44-55.
[8] Mohan V, Deepa M, Farooq S, et al. Prevalence, awareness and control of hypertension in Chennai - The Chennai Urban Rural Epidemiology Study (CURES-52).J Assoc Physicians India 2007;55:326-32.
[9] Deshmukh PR, Gupta SS, Bharambe MS, et al. Prevalence of the metabolic syndrome in rural India: a population-based study. Diabetes Care 2008;31(9):1856-8.
[10] Ranasinghe P, Mathangasinghe Y, Jayawardena R, et al. Prevalence and risk factors for metabolic syndrome among adults in Sri Lanka: a cross-sectional study. BMC Public Health 2017;17(1):272.
[11] Hildrum B, Mykletun A, Hole T, et al. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: The Norwegian HUNT 2 study. BMC Public Health 2007;7:220.
[12] Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 2004;20(5):482-91.
[13] Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287(3):356-9.
[14] Bajaj S, Nigam P. Metabolic syndrome - awareness and management. J Assoc Physicians India 2009;57:656-63.
[15] Yadav D, Mahajan S, Subramanian SK, et al. Prevalence of metabolic syndrome and its association with leisure time physical activity and socio-economic status in North India. Metab Syndr Relat Disord 2013;11(5):364-9.
[16] Grundy SM, Cleeman JI, Daniels SR, et al. Definition of metabolic syndrome. In: Harrison’s Principles of Internal Medicine. 21st ed. Chapter 408. McGraw-Hill; 2022.